Re: Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
Ribas
A
A
Albanell
J
J
Bellmunt
J
J
Solé-Calvo
L A
LA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D004334:Drug Administration Schedule; D004357:Drug Synergism; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced; D010976:Platelet Count / Q000187:drug effects; D011446:Prospective Studies; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000517:prevention & control; D013997:Time Factors
D016179:Granulocyte Colony-Stimulating Factor